Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Influence of cell-penetrating peptides on the activity and stability of virus-based nanoparticles.

Váňová J, Hejtmánková A, Žáčková Suchanová J, Sauerová P, Forstová J, Hubálek Kalbáčová M, Španielová H.

Int J Pharm. 2019 Dec 31;576:119008. doi: 10.1016/j.ijpharm.2019.119008. [Epub ahead of print]

PMID:
31901358
2.

The Utilization of Cell-Penetrating Peptides in the Intracellular Delivery of Viral Nanoparticles.

Váňová J, Hejtmánková A, Kalbáčová MH, Španielová H.

Materials (Basel). 2019 Aug 22;12(17). pii: E2671. doi: 10.3390/ma12172671. Review.

3.

Prevalence of antibodies against BKPyV subtype I and IV in kidney transplant recipients and in the general Czech population.

Hejtmánková A, Roubalová K, Forejtová A, Žáčková Suchanová J, Forstová J, Viklický O, Španielová H.

J Med Virol. 2019 May;91(5):856-864. doi: 10.1002/jmv.25388. Epub 2019 Jan 16.

PMID:
30609063
4.

Inhibitor-GCPII Interaction: Selective and Robust System for Targeting Cancer Cells with Structurally Diverse Nanoparticles.

Neburkova J, Sedlak F, Zackova Suchanova J, Kostka L, Sacha P, Subr V, Etrych T, Simon P, Barinkova J, Krystufek R, Spanielova H, Forstova J, Konvalinka J, Cigler P.

Mol Pharm. 2018 Aug 6;15(8):2932-2945. doi: 10.1021/acs.molpharmaceut.7b00889. Epub 2018 Feb 13.

PMID:
29389139
5.

Hydrophobic domains of mouse polyomavirus minor capsid proteins promote membrane association and virus exit from the ER.

Huérfano S, Ryabchenko B, Španielová H, Forstová J.

FEBS J. 2017 Mar;284(6):883-902. doi: 10.1111/febs.14033. Epub 2017 Feb 23.

6.

Retargeting Polyomavirus-Like Particles to Cancer Cells by Chemical Modification of Capsid Surface.

Zackova Suchanova J, Neburkova J, Spanielova H, Forstova J, Cigler P.

Bioconjug Chem. 2017 Feb 15;28(2):307-313. doi: 10.1021/acs.bioconjchem.6b00622. Epub 2017 Jan 10.

PMID:
28035816
7.

Mouse Polyomavirus: Propagation, Purification, Quantification, and Storage.

Horníková L, Žíla V, Španielová H, Forstová J.

Curr Protoc Microbiol. 2015 Aug 3;38:14F.1.1-26. doi: 10.1002/9780471729259.mc14f01s38.

PMID:
26237106
8.

The encapsidation of polyomavirus is not defined by a sequence-specific encapsidation signal.

Spanielová H, Fraiberk M, Suchanová J, Soukup J, Forstová J.

Virology. 2014 Feb;450-451:122-31. doi: 10.1016/j.virol.2013.12.010. Epub 2013 Dec 31.

9.

The Cre/loxP recombination system for production of infectious mouse polyomavirus.

Hron T, Spanielová H, Suchanová J, Forstová J.

Virus Res. 2013 Sep;176(1-2):128-36. doi: 10.1016/j.virusres.2013.05.016. Epub 2013 Jun 22.

PMID:
23800406
10.

Minor capsid proteins of mouse polyomavirus are inducers of apoptosis when produced individually but are only moderate contributors to cell death during the late phase of viral infection.

Huerfano S, Zíla V, Boura E, Spanielová H, Stokrová J, Forstová J.

FEBS J. 2010 Mar;277(5):1270-83. doi: 10.1111/j.1742-4658.2010.07558.x. Epub 2010 Feb 1.

11.

Supplemental Content

Loading ...
Support Center